DK1461063T3 - Behandling af glioblastom med thymosin-alfa 1 - Google Patents

Behandling af glioblastom med thymosin-alfa 1

Info

Publication number
DK1461063T3
DK1461063T3 DK02804755T DK02804755T DK1461063T3 DK 1461063 T3 DK1461063 T3 DK 1461063T3 DK 02804755 T DK02804755 T DK 02804755T DK 02804755 T DK02804755 T DK 02804755T DK 1461063 T3 DK1461063 T3 DK 1461063T3
Authority
DK
Denmark
Prior art keywords
glioblastoma
treatment
thymosin alpha
thymosin
alpha
Prior art date
Application number
DK02804755T
Other languages
English (en)
Inventor
La Monte Suzanne De
Jack R Wands
Original Assignee
Rhode Island Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital
Application granted granted Critical
Publication of DK1461063T3 publication Critical patent/DK1461063T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02804755T 2001-12-10 2002-12-10 Behandling af glioblastom med thymosin-alfa 1 DK1461063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33714901P 2001-12-10 2001-12-10
PCT/US2002/039329 WO2003049697A2 (en) 2001-12-10 2002-12-10 Treatment of glioblastoma with thymosin-alpha 1

Publications (1)

Publication Number Publication Date
DK1461063T3 true DK1461063T3 (da) 2007-05-21

Family

ID=23319320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02804755T DK1461063T3 (da) 2001-12-10 2002-12-10 Behandling af glioblastom med thymosin-alfa 1

Country Status (22)

Country Link
US (1) US20060166870A1 (da)
EP (1) EP1461063B1 (da)
JP (1) JP2005516910A (da)
KR (2) KR20040091611A (da)
CN (1) CN1615147A (da)
AT (1) ATE356628T1 (da)
AU (1) AU2002357115B2 (da)
BR (1) BR0214848A (da)
CA (1) CA2469595A1 (da)
DE (1) DE60218896T2 (da)
DK (1) DK1461063T3 (da)
EA (1) EA005822B1 (da)
ES (1) ES2283653T3 (da)
IL (1) IL162434A0 (da)
MX (1) MXPA04005585A (da)
NO (1) NO20042927L (da)
NZ (1) NZ533942A (da)
PL (1) PL370829A1 (da)
PT (1) PT1461063E (da)
SI (1) SI1461063T1 (da)
UA (1) UA77999C2 (da)
WO (1) WO2003049697A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288118B1 (es) 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
CN108226016A (zh) * 2018-01-12 2018-06-29 浙江普罗亭健康科技有限公司 肿瘤免疫细胞亚群精准分型的质谱流式检测试剂盒
CN112147326B (zh) * 2020-09-04 2022-04-08 北京大学 一种肿瘤免疫细胞亚群分型精准检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
IT1238231B (it) * 1989-12-18 1993-07-12 Consiglio Nazionale Ricerche Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
FR2793684B1 (fr) * 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US6462017B1 (en) * 2000-05-01 2002-10-08 Sciclone Pharmaceuticals, Inc. Method of reducing side effects of chemotherapy in cancer patients

Also Published As

Publication number Publication date
EP1461063B1 (en) 2007-03-14
DE60218896T2 (de) 2007-09-20
WO2003049697A2 (en) 2003-06-19
NO20042927L (no) 2004-09-09
ATE356628T1 (de) 2007-04-15
PT1461063E (pt) 2007-06-18
EA200400755A1 (ru) 2004-12-30
WO2003049697A3 (en) 2004-01-15
NZ533942A (en) 2007-01-26
ES2283653T3 (es) 2007-11-01
CN1615147A (zh) 2005-05-11
AU2002357115A1 (en) 2003-06-23
BR0214848A (pt) 2004-11-09
JP2005516910A (ja) 2005-06-09
EP1461063A2 (en) 2004-09-29
MXPA04005585A (es) 2005-03-23
CA2469595A1 (en) 2003-06-19
UA77999C2 (en) 2007-02-15
EP1461063A4 (en) 2005-08-31
IL162434A0 (en) 2005-11-20
PL370829A1 (en) 2005-05-30
EA005822B1 (ru) 2005-06-30
KR20040091611A (ko) 2004-10-28
AU2002357115B2 (en) 2007-12-13
DE60218896D1 (de) 2007-04-26
KR20100029844A (ko) 2010-03-17
US20060166870A1 (en) 2006-07-27
SI1461063T1 (sl) 2007-08-31

Similar Documents

Publication Publication Date Title
BR0309492A (pt) Uso de pelo menos um álcool ramificado alcoxilado
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
CY2014031I1 (el) Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
PA8557401A1 (es) Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
BR0215405A (pt) Composições e processos de uso de collajolie
ATE433963T1 (de) Fab-i inhibitoren
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
NO20043313L (no) Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE60112960D1 (de) Kondensierte pyridoindolderivate
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas
DK1461063T3 (da) Behandling af glioblastom med thymosin-alfa 1
DE60121048D1 (de) PYRAZINOi1&#39;2&#39;:1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
SE0302361D0 (sv) Inhibering av upptagning av monoamin
DK1274426T3 (da) Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DE60124148D1 (de) Kalzilytische verbindungen
DE60219788D1 (de) Tetrazyklische verbindungen als pde5-inhibitoren
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer